Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism

Summary

The purpose of this study is to evaluate the safety and efficacy of Testogel® 50mg/5g gel administered once daily (QD, morning dosing) compared to placebo administered once daily (QD, morning dosing), for 3 months, in hypogonadal men with testosterone deficiency being confirmed by clinical features and biochemical tests. For men with hypogonadism, treatment aims to restore testosterone levels to normal physiological range.

Timeline

Start

2012-12

Primary completion

2014-12

Completion

—

Drugs

Indications